-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on UiPath, Raises Price Target to $16

Benzinga·06/02/2025 13:42:16
Listen to the news
Canaccord Genuity analyst Kingsley Crane maintains UiPath (NYSE:PATH) with a Buy and raises the price target from $14 to $16.